ORLANDO—Men who present with Peyronie’s disease (PD) at age 29 years or younger are less satisfied with PD treatment compared with PD patients in other age groups, according to Canadian study findings presented at the American Urological Association 2014 annual meeting.
Anthony J Bella, MD, and colleagues at the University of Ottawa studied 289 men treated medically, surgically, or both from September 2011 through September 2012. Patients were followed through at least September 2013. The investigators stratified subjects by age: 29 years or younger, 30-39, 40-49, and so forth. Of the 24 patients aged 29 years or younger, 23 completed follow-up.
Although patient-reported psychological impact was similar across age groups, psychosocial burden was increased and PD treatment satisfaction and outcomes measures—including specific domains of end-of-treatment International Index of Erectile Function-5 scores for erectile dysfunction—were decreased in men aged 29 years and younger compared with patients in other age groups. Dr. Bella’s group reported.
The authors concluded in their study abstract that their findings “reinforce that younger men comprise a unique subset of PD patients biologically, as previously published, but also psychologically, with expectations of a return to ‘complete normalcy even when counseled carefully on evidence-based outcomes of treatment.”